Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma Gangrenosum

NCT01882504 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

XOMA (US) LLC